Management of Contaminated Urine Specimen with Candiduria in a Male Patient
In a male patient with a contaminated urine specimen showing candiduria, you should first repeat the urine culture with a properly collected specimen to confirm true candiduria, and you should NOT initiate empiric antifungal therapy unless the patient has urinary symptoms, is neutropenic, is critically ill, or is about to undergo urologic manipulation 1, 2.
Initial Assessment and Specimen Collection
The presence of numerous squamous epithelial cells indicates contamination, making the clinical significance of candiduria impossible to determine 2. Your immediate steps should be:
- Obtain a repeat urine specimen using proper collection technique to verify true funguria 2, 3
- In males, this typically means a midstream clean-catch specimen or, if necessary, straight catheterization (not an indwelling catheter)
- Look specifically for: urinary symptoms (dysuria, frequency, urgency, flank pain), fever, signs of sepsis, presence of indwelling urinary catheter, recent urologic procedures, neutropenia, diabetes mellitus, and immunosuppression 1, 3
Decision Algorithm for Antifungal Therapy
DO NOT TREAT if the patient is:
- Asymptomatic with confirmed candiduria
- Has no high-risk features
- Has no planned urologic procedures
This represents the vast majority of candiduria cases and treatment is NOT recommended 1. The IDSA guideline explicitly states that antifungal treatment is not recommended unless the patient belongs to a high-risk group 1.
DO TREAT if the patient has ANY of these high-risk features:
1. Neutropenia: Treat as candidemia with systemic antifungal therapy 1
2. Planned urologic procedure within days: Give fluconazole 400 mg (6 mg/kg) daily OR amphotericin B deoxycholate 0.3-0.6 mg/kg daily for several days before and after the procedure 1
3. Symptomatic cystitis (dysuria, frequency, urgency):
- For fluconazole-susceptible species: Fluconazole 200 mg (3 mg/kg) daily for 2 weeks 1
- For fluconazole-resistant C. glabrata: Amphotericin B deoxycholate 0.3-0.6 mg/kg daily for 1-7 days OR flucytosine 25 mg/kg four times daily for 7-10 days 1
- For C. krusei: Amphotericin B deoxycholate 0.3-0.6 mg/kg daily for 1-7 days 1
4. Symptomatic pyelonephritis (fever, flank pain, systemic symptoms):
- For fluconazole-susceptible species: Fluconazole 200-400 mg (3-6 mg/kg) daily for 2 weeks 1
- Adjust based on species and susceptibility as above 1
5. Critically ill patients: Consider candiduria as a potential marker for invasive candidiasis and evaluate thoroughly 2
Critical Management Steps Beyond Antifungals
Remove or replace indwelling urinary catheters whenever feasible - this is a strong recommendation and often more important than antifungal therapy 1. Catheter removal alone frequently resolves candiduria without antifungal treatment 3, 4.
Common Pitfalls to Avoid
- Overtreatment is extremely common - studies show that 23-31% of candiduria patients receive unnecessary antifungal therapy 5, 6
- Do not use echinocandins for candiduria - they are poorly excreted in urine and ineffective 4
- Do not rely on colony counts - they have not proven diagnostically useful for candiduria 2
- Do not assume candiduria equals candidemia - ascending infection and bloodstream dissemination are rare in non-neutropenic patients 3, 7
Imaging Considerations
If the patient is symptomatic or critically ill with confirmed candiduria, obtain renal ultrasound as the initial imaging study to evaluate for hydronephrosis, obstruction, or fungal balls 2. CT scan is superior for detecting pyelonephritis or perinephric abscess 2.
The evidence strongly supports a conservative approach: verify the diagnosis with proper specimen collection, eliminate predisposing factors (especially catheters), and reserve antifungal therapy only for high-risk or symptomatic patients 1, 3, 4.